Table 2 Characteristic on the starting medication day.
On the starting medication day | EE/GS n = 18 | DRSP n = 18 | p-valuea |
|---|---|---|---|
Cycle day at starting medication, n (%) | 0.319 | ||
Day 7 | 6 (35.29) | 5 (29.41) | |
Day 8 | 5 (29.41) | 9 (52.94) | |
Day 9 | 6 (35.29) | 3 (17.65) | |
Largest follicle diameter | |||
Mean ± SD | 10.75 ± 3.80 | 9.76 ± 2.03 | 0.351 |
Median (IQR) | 11.70 (8.40–11.80) | 10.40 (8.40–10.80) | – |
Estradiol (pg/mL) | |||
Mean ± SD | 112.62 ± 94.54 | 68.34 ± 33.91 | – |
Median (IQR) | 66.54 (37.89, 139.19) | 69.87 (42.89, 76.24) | 0.502 |
Progesterone (ng/dL) | |||
Mean ± SD | 0.24 ± 0.17 | 0.39 ± 0.83 | – |
Median (IQR) | 0.19 (0.17, 0.30) | 0.13 (0.10, 0.30) | 0.407 |
LH (IU/L) | |||
Mean ± SD | 7.45 ± 4.83 | 6.52 ± 1.98 | – |
Median (IQR) | 5.55 (4.34–8.20) | 6.71 (4.76–7.50) | 0.945 |
Cervical mucus (modified WHO score) | |||
Mean ± SD | 5.35 ± 2.00 | 4.41 ± 1.42 | 0.123 |
Median (IQR) | 5 (4–6) | 4 (4–5) | – |
Hoogland and Skouby Score at starting medication day, n (%) | 0.785 | ||
No activity | 8 (47.06) | 9 (52.94) | |
Potential activity | 6 (35.29) | 7 (41.18) | |
Non-active FLS | – | – | |
Active FLS | 3 (17.65) | 1 (5.88) | |
LUF | – | – | |
Ovulation | – | – | |
